QuVA Pharma
Private Company
Funding information not available
Overview
QuVA Pharma is a unique hybrid company operating at the intersection of pharmaceutical manufacturing and health-tech analytics. Founded in 2021 and headquartered in Boston, it leverages over a decade of compounding expertise to supply sterile injectables while integrating AI-powered software to optimize hospital pharmacy operations. Its dual business model addresses critical pain points like drug shortages, inventory waste, and revenue leakage, positioning it as a comprehensive partner for health-system pharmacies seeking to improve efficiency and patient care.
Technology Platform
Quva BrightStream: An AI-powered SaaS analytics platform that ingests data from over 350 sources across health systems to provide actionable insights for pharmacy operations, including shortage management, diversion surveillance, inventory optimization, and revenue capture.
Opportunities
Risk Factors
Competitive Landscape
In sterile injectable compounding, Quva competes with other large 503B outsourcing facilities. In analytics, it competes with a range of healthcare SaaS companies offering pharmacy, supply chain, and revenue cycle management tools. Its hybrid model is distinctive but must prove superior to using separate best-of-breed vendors.